Arvinas Inc share price logo

Arvinas Inc Share Price

NASDAQ: ARVN

Small Cap

$13.73

-0.03

(-0.22%)

as on

Arvinas Inc Stock Performance

as on March 6, 2026 at 7:59 am IST

  • Day's Low

    Day's High

    $13.20
    $13.98
    downward going graph

    3.86%

    Downside

    1.82%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $5.90
    $18.93
    downward going graph

    57.03%

    Downside

    37.87%

    Upside

    downward going graph

Arvinas Inc share price movements today

Previous Close
$13.76
Open
$13.72
Volume
956.6K
Day's Low - High
$13.20 - $13.98
52 Week Low - High
$5.90 - $18.93

Arvinas Inc Historical Returns

1 Month Return
+ 6.17 %
3 Month Return
+ 7.58 %
1 Year Return
-21.35 %
3 Year Return
-56.16 %
5 Year Return
-80.9 %

Arvinas Inc Stock Fundamentals & Key Indicators

Check Arvinas Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$980.9M

EPS (TTM)

-3.5558

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-5.53

Industry PE ratio

-3.3064705882352943

PEG Ratio

0

EBITDA

-111.9M

Revenue (TTM)

262.6M

Profit Margin

-30.77%

Return On Equity TTM

-16.23%

Arvinas Inc Stock Valuation

Track how Arvinas Inc P/E has moved over time to understand its valuation trends.

Arvinas Inc in the last 5 years

  • Overview

  • Trends

Lowest (-23.74x)

March 31, 2025

Today (-5.53x)

March 5, 2026

Industry (-3.31x)

March 5, 2026

Highest (-3.60x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -5.53x

Arvinas Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Arvinas Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Arvinas Inc image
Arvinas Inc
BUY$980.9M-80.9%-5.53-30.77%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$120.5B125.44%30.9632.94%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$42.3B128.26%136.768.45%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$32.9BNA560.455.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$81.1B70.61%18.4831.41%

Stock Returns calculator for Arvinas Inc Stock including INR - Dollar returns

The Arvinas Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Arvinas Inc investment value today

Current value as on today

₹83,829

Returns

₹16,171

(-16.17%)

Returns from Arvinas Inc Stock

₹21,543 (-21.54%)

Dollar Returns*

₹5,372 (+5.37%)

Analyst Recommendation on Arvinas Inc Stock

Based on 26 analysts

BUY

88.46%

Buy

11.54%

Hold

0.00%

Sell

Based on 26 analysts, 88.46% of analysts recommend a 'BUY' rating for Arvinas Inc. Average target price of $14.25

Arvinas Inc Share Price Target

Get share price movements and forecasts by analysts on Arvinas Inc.

What analysts predicted

3.65%UPSIDE

Target Price

$14.25

Current Price

$13.73

Analyzed by

26 Analysts

Target

$14.25

Arvinas Inc target price $14.25, a slight upside of 3.65% compared to current price of $13.73. According to 26 analysts rating.

Arvinas Inc Stock’s Investor Sentiment and Interest

Search interest for Arvinas Inc Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-11% versus previous 30 day period

Arvinas Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
34
-43
25
76
102
59
188
22
41
9
Gross Profit
32
-44
23
74
102
59
188
22
41
8
Operating Income
-73
-165
-83
-48
-60
-58
71
-71
-43
-71
EBITDA
-62
-163
-81
-46
-59
-56
72
-70
-34
-66
Interest Expense
-
7
-
-
-
-
-
-
-
-
Depreciation
1
1
1
1
1
1
1
1
1
-
Income Before Tax
-64
-153
-69
-35
-48
-45
83
-61
-34
-67
Income Tax Expense
0
1
0
0
0
0
0
0
0
0
Net Income
-64
-154
-69
-35
-49
-45
82
-61
-35
-67
Net Profit Margin
-184.97%
359.16%
-274.31%
-46.01%
-48.05%
-76.18%
43.91%
-273.21%
-83.77%
-709.47%

Arvinas Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
6
7
14
42
21
46
131
78
263
262
Gross Profit
6
7
14
42
21
46
131
78
263
257
Operating Income
-16
-24
-43
-51
-124
-195
-263
-401
-250
-114
EBITDA
-13
-23
-43
-49
-120
-189
-255
-394
-243
-75
Interest Expense
0
0
0
0
0
0
12
-
-
-
Depreciation
-
0
0
2
4
6
8
7
6
-
Income Before Tax
-14
-24
-41
-70
-119
-191
-251
-366
-198
-80
Income Tax Expense
0
0
2
-8
-7
-7
20
0
0
0
Net Income
-14
-24
-41
-62
-111
-183
-271
-367
-198
-80
Net Profit Margin
-215.18%
-317.32%
-289.59%
-144.57%
-512.74%
-392.29%
-206.93%
-467.90%
-75.51%
-30.77%

Arvinas Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-154
-69
-35
-49
-45
82
-61
-35
-67
Operating Cash Flow
-83
-97
50
-128
-84
-88
-95
-59
-30
Investing Cash Flow
-53
-127
13
50
98
69
128
63
145
Financing Cash Flow
334
1
3
2
0
0
0
-17
-74
Change in Cash
198
-223
66
-75
15
-19
33
-13
41

Arvinas Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-24
-41
-70
-119
-191
-282
-367
-198
-80
Operating Cash Flow
5
-16
-40
-89
559
-273
-347
-259
-273
Investing Cash Flow
20
-179
-93
164
-1,313
242
203
34
407
Financing Cash Flow
0
168
139
504
278
4
374
7
-91
Change in Cash
25
-27
6
579
-475
-26
230
-216
42

Global Institutional Holdings in Arvinas Inc

Funds
Holdings
Vanguard Group Inc
11.3%
Pfizer Inc
5.41%
State Street Corp
2.93%
Morgan Stanley - Brokerage Accounts
2.6%
Monaco Asset Management
1.11%
See all

Arvinas Inc News & Key Events

  • img

    Today's Timeline - 17 September

    Thu, 02:00 AM

    -

    Arvinas and Pfizer to out-license vepdegestrant commercialization rights; $100 million stock repurchase program authorized.

Insights on Arvinas Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, ARVN stock has moved up by 75.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 31.9% return, outperforming this stock by 55.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 63.9% return, outperforming this stock by 119.4%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 41.9M → 9.5M (in $), with an average decrease of 77.3% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -35.1M → -67.4M (in $), with an average decrease of 92.0% per quarter

About Arvinas Inc

arvinas is a pharmaceutical company focused on developing new small molecules ‒ known as protacs (proteolysis targeting chimeras) ‒ aimed at degrading disease-causing cellular proteins via proteolysis. based on innovative research conducted at yale university by dr. craig crews, founder and chief scientific advisor, the company is translating natural protein degradation approaches into novel drugs for the treatment of cancer and other diseases. the proprietary protac-based drug paradigm induces protein degradation, rather than protein inhibition, using the ubiquitin proteasome system and offers the advantage of potentially targeting “undruggable” as well as “druggable” elements of the proteome. this greatly expands the ability to create drugs for many new, previously unapproachable targets. for more information, visit www.arvinas.com.
OrganisationArvinas Inc
Headquarters5 Science Park, New Haven, CT, United States, 06511
IndustryHealth Technology
CEODr. Randy Teel Ph.D.
E-voting on sharesClick here to vote

Key Management of Arvinas Inc

Name

Title

Mr. Andrew R. Saik

CFO & Treasurer

Dr. Noah Berkowitz M.D., Ph.D.

Chief Medical Officer

Mr. Steve Weiss

Senior VP & Chief Human Resources Officer

Ms. Lisa Sinclair

Senior Vice President of Corporate Operations

Mr. Jared M. Freedberg J.D.

General Counsel & Corporate Secretary

Mr. Paul McInulty

Senior Vice President of Regulatory Affairs

Dr. Randy Teel Ph.D.

CEO, President & Director

Ms. Angela M. Cacace Ph.D.

Chief Scientific Officer

Mr. David K. Loomis M.B.A.

VP & Chief Accounting Officer

Mr. Jeff Boyle

Vice President of Investor Relations

FAQs

What is Arvinas Inc share price today?

Arvinas Inc share price today is $13.73 as on at the close of the market. Arvinas Inc share today touched a day high of $13.98 and a low of $13.2.

What is the 52 week high and 52 week low for Arvinas Inc share?

Arvinas Inc share touched a 52 week high of $18.93 on and a 52 week low of $5.9 on . Arvinas Inc stock price today i.e. is closed at $13.73,which is 27.47% down from its 52 week high and 132.71% up from its 52 week low.

What is Arvinas Inc's market capitalisation today?

Arvinas Inc market capitalisation is $0.00T as on .

How to invest in Arvinas Inc Stock (ARVN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Arvinas Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Arvinas Inc Shares that will get you 0.1092 shares as per Arvinas Inc share price of $13.73 per share as on March 6, 2026 at 2:29 am IST.

What is the minimum amount required to buy Arvinas Inc Stock (ARVN) from India?

Indian investors can start investing in Arvinas Inc (ARVN) shares with as little as ₹91.558 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹915.58 in Arvinas Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Arvinas Inc share’s latest price of $13.73 as on March 6, 2026 at 2:29 am IST, you will get 0.7283 shares of Arvinas Inc. Learn more about fractional shares .

What are the returns that Arvinas Inc has given to Indian investors in the last 5 years?

Arvinas Inc stock has given -80.9% share price returns and 25.13% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?